Carlos Roca
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Multitask Deep Neural Networks for Ames Mutagenicity Prediction.
Journal: Journal of chemical information and modeling
Published: September 06, 2022
AI in drug development: a multidisciplinary perspective.
Journal: Molecular diversity
Published: April 21, 2021
Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2016-2019).
Journal: Expert opinion on therapeutic patents
Published: August 26, 2020
QSAR Classification Models for Predicting the Activity of Inhibitors of Beta-Secretase (BACE1) Associated with Alzheimer's Disease.
Journal: Scientific reports
Published: January 31, 2019
Indazolylketones as new multitarget cannabinoid drugs.
Journal: European journal of medicinal chemistry
Published: October 24, 2018
Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors.
Journal: Journal of medicinal chemistry
Published: August 07, 2018
Deciphering the Inhibition of the Neuronal Calcium Sensor 1 and the Guanine Exchange Factor Ric8a with a Small Phenothiazine Molecule for the Rational Generation of Therapeutic Synapse Function Regulators.
Journal: Journal of medicinal chemistry
Published: July 03, 2018
Identification of new allosteric sites and modulators of AChE through computational and experimental tools.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: June 07, 2018
Chameleon-like behavior of indolylpiperidines in complex with cholinesterases targets: Potent butyrylcholinesterase inhibitors.
Journal: European journal of medicinal chemistry
Published: October 26, 2017
Medicinal and Biological Chemistry (MBC) Library: An Efficient Source of New Hits.
Journal: Journal of chemical information and modeling
Published: August 17, 2017
From dual binding site acetylcholinesterase inhibitors to allosteric modulators: A new avenue for disease-modifying drugs in Alzheimer's disease.
Journal: European journal of medicinal chemistry
Published: July 06, 2017
Last Updated: 09/26/2026